Delivery Order SPE2DB24D2205-SPE2DB25FEFRW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a contract value of $1,468.47. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $1,049.68. This firm fixed-price delivery order, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a contract value of $1,250.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The work is to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,048.50 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.70 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 5 mg capsules (100 count). This competitive award, issued on July 25, 2025, represents a firm fixed price transaction with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,433.30 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFRWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $2,024.24, with a performance period through August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania corporate office location. The award represents a pediatric neurological medication commonly used to treat attention deficit hyperactivity disorder, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant role in the federal medical supply chain and has demonstrated capability to meet government procurement requirements through competitive award mechanisms across multiple therapeutic domains and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/1/25 |